Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind,randomised, placebo-controlled trial |
| |
| Affiliation: | 1. Chinese PLA General Hospital, Beijing, China;2. Nowon Eulji Medical Center, Seoul, South Korea;3. Yan’an University Xianyang Hospital, Xianyang, China;4. Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea;5. Changsha Central Hospital, Changsha, China;6. Wuhan Third Hospital, Wuhan, China;7. Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea;8. The First Affiliated Hospital of Chongqing Medical University, Chongqing, China;9. Shanxi Provincial Hospital, Xi’an, China;10. Biohaven Pharmaceuticals, New Haven, CT, USA;11. BioShin Limited, Shanghai, China;1. Department of Neurology and Stroke Center, APHP, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, University of Paris-Cité, Paris, France;2. Population Health Research Institute, McMaster University, Hamilton, ON, Canada;3. Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University Medical Center, Stanford, CA, USA;4. Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA, USA;5. Melbourne Brain Centre, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia;6. Instituto de Medicina Molecular João Lobo Antunes, Universidade de Lisboa, Lisbon, Portugal;7. Department of Neurology, Universitäts Medizin Mannheim, Heidelberg University, Heidelberg, Germany;8. Department of Biostatistics, CHU Lille, Lille, France;9. Department of Neurology, Stroke Unit, Vall d’Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain;10. Nuffield Department of Clinical Neuroscience, Wolfson Centre for Prevention of Stroke and Dementia, University of Oxford, Oxford, UK;11. Department of Cardiology, APHP, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Université Paris Cité, Paris, France;12. Institut Universitaire de France, Paris, France;13. Center for Brain and Cerebral Vessels, International University of Health and Welfare, Sanno Hospital and Sanno Medical Center, Tokyo, Japan;14. Department of Biostatistics, APHP, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal Hospital, Paris, France;15. Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China;1. Department of Clinical Neuroscience, University of Cambridge, Cambridge, CB2 0AH, UK;2. Microscopic and Ultrastructural Anatomy Research Unit-Integrated Research Centre (PRABB), Campus Biomedico University of Rome, Rome, Italy;1. Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, China;2. Global Brain Health Program, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia;1. Brain Research Africa Initiative, Geneva, Switzerland;2. Yaoundé, PO Box 25625, Cameroon;3. Neuroscience Laboratory, Faculty of Medicine and Biomedical Sciences, The University of Yaoundé I, Yaoundé, Cameroon;4. Neurology Department, Yaoundé Central Hospital, Yaoundé, Cameroon;5. Department of Health Operations Research, Ministry of Public Health, Yaoundé, Cameroon;6. Neurology Division, Fribourg Hospital, Fribourg, Switzerland;7. Faculty of Medicine and Science, University of Fribourg, Fribourg, Switzerland;8. Robarts Research Institute, University of Western Ontario, London, ON, Canada;9. Department of Clinical Neurological Sciences, University of Western Ontario, London, ON, Canada;1. Department of Neurology, Centro Hospitalar Universitário de Santo António, Porto 4099-001, Portugal;2. Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal;3. i3S—Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
